Smith Jason Drew
UroGen Pharma Ltd. · General Counsel
Smith Jason Drew is listed in filings as General Counsel at UroGen Pharma Ltd.. This profile follows SEC Form 4 activity through Feb 11, 2026, including sale activity. Recent filings connect the profile to UroGen Pharma Ltd. (URGN). The current snapshot covers public activity from Sep 12, 2024 to Feb 11, 2026. Reported amounts are shown as $63.3K to $31.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $63k3.2k shares | SellFeb 3, 2026 | $19.69 | $39.81 | |
| $52k2.7k shares | SellFeb 3, 2026 | $19.69 | $39.81 | |
| $32k1.6k shares | SellFeb 3, 2026 | $19.69 | $39.81 |